n-methyl-n-propargyl-(1-indanyl)-ammonium hydrochloride has been researched along with selegiline in 4 studies
Studies (n-methyl-n-propargyl-(1-indanyl)-ammonium hydrochloride) | Trials (n-methyl-n-propargyl-(1-indanyl)-ammonium hydrochloride) | Recent Studies (post-2010) (n-methyl-n-propargyl-(1-indanyl)-ammonium hydrochloride) | Studies (selegiline) | Trials (selegiline) | Recent Studies (post-2010) (selegiline) |
---|---|---|---|---|---|
6 | 0 | 0 | 2,575 | 319 | 394 |
Protein | Taxonomy | n-methyl-n-propargyl-(1-indanyl)-ammonium hydrochloride (IC50) | selegiline (IC50) |
---|---|---|---|
Cholinesterase | Homo sapiens (human) | 0.0055 | |
Cytochrome P450 3A4 | Homo sapiens (human) | 0.0039 | |
Alpha-2A adrenergic receptor | Homo sapiens (human) | 1.798 | |
Alpha-2B adrenergic receptor | Homo sapiens (human) | 0.376 | |
Amine oxidase [flavin-containing] B | Rattus norvegicus (Norway rat) | 0.2127 | |
Amine oxidase [flavin-containing] A | Rattus norvegicus (Norway rat) | 0.9046 | |
Amine oxidase [flavin-containing] A | Homo sapiens (human) | 1.4408 | |
Adenosine receptor A1 | Rattus norvegicus (Norway rat) | 0.0067 | |
Amine oxidase [flavin-containing] B | Homo sapiens (human) | 0.1001 | |
Type-1 angiotensin II receptor | Sus scrofa (pig) | 0.048 | |
Alpha-synuclein | Homo sapiens (human) | 0.27 | |
Amine oxidase [flavin-containing] B | Bos taurus (cattle) | 1 | |
Sigma intracellular receptor 2 | Rattus norvegicus (Norway rat) | 0.017 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (75.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Knoll, B; Timár, J | 1 |
Finberg, JP; Youdim, MB | 1 |
Callingham, BA; Fowler, CJ; Oreland, L | 1 |
Miklya, I | 1 |
1 review(s) available for n-methyl-n-propargyl-(1-indanyl)-ammonium hydrochloride and selegiline
Article | Year |
---|---|
The acetylenic monoamine oxidase inhibitors clorgyline, deprenyl, pargyline and J-508: their properties and applications.
Topics: Alkynes; Animals; Binding Sites; Clorgyline; Indans; Indenes; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Pargyline; Phenethylamines; Propylamines; Rats; Selegiline; Substrate Specificity | 1981 |
3 other study(ies) available for n-methyl-n-propargyl-(1-indanyl)-ammonium hydrochloride and selegiline
Article | Year |
---|---|
The effect of repeated administration of (-) deprenyl on the phenylethylamine-induced stereotypy in rats.
Topics: Alkynes; Animals; Clorgyline; Female; Indans; Male; Monoamine Oxidase Inhibitors; Pargyline; Phenethylamines; Rats; Rats, Inbred Strains; Selegiline; Stereotyped Behavior | 1986 |
MAO type B inhibitors as adjunct to L-dopa therapy.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Alkynes; Animals; Brain; Drug Therapy, Combination; Humans; Indans; Isoenzymes; Levodopa; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Pargyline; Parkinson Disease; Parkinson Disease, Secondary; Pyridines; Receptors, Dopamine; Selegiline; Structure-Activity Relationship; Tyramine | 1987 |
[A comparison of the pharmacology of (-)-deprenyl to N-methylpropargylamine-1-aminoindane (J-508) and rasagiline, the desmethyl-analogue of J-508].
Topics: Adrenergic Uptake Inhibitors; Animals; Brain Stem; Catecholamines; Clorgyline; Indans; Learning; Monoamine Oxidase Inhibitors; Neurons; Neuroprotective Agents; Pargyline; Rats; Selegiline; Tetrabenazine | 2008 |